Antibiotic-resistant bacterial infections arising from acquired resistance and/or through
biofilm formation necessitate the development of innovative 'outside of the box'therapeutics …

The wide spread of antibiotic resistance has been alarming in recent years and poses a
serious global hazard to public health as it leads to millions of deaths all over the world. The …

Nanoparticles have immense industrial, biotechnological, and biomedical/pharmaceutical
applications due to their pliability in structure, size, biocompatibility, high surface area, and …

The clinical applications of nanotechnology are emerging as widely popular, particularly as
a potential treatment approach for infectious diseases. Diseases associated with multiple …

For decades infections have been treated easily with drugs. However, in the 21st century,
they may become lethal again owing to the development of antimicrobial resistance …

Pseudomonas aeruginosa is a leading cause of nosocomial infections and is responsible
for∼ 10% of all hospital-acquired infections worldwide. It continues to pose a therapeutic …

Since the dawn of civilization, it has been understood that pathogenic microorganisms
cause infectious conditions in humans, which at times, may prove fatal. Among the different …

Biofilms are matrix-enclosed communities of bacteria that show increased antibiotic
resistance and the capability to evade the immune system. They can cause recalcitrant …

Background Controlled release and targeted delivery of the drug payload are the two most
fascinating applications of nanoparticle-based systems explored in the recent past. The …

In the field of antibiotherapy, intracellular infections remain difficult to eradicate mainly due to
the poor intracellular penetration of most of the commonly used antibiotics. Bacteria have …